Trial ID: | L0452 |
Source ID: | NCT01157260
|
Associated Drug: |
Kremezin
|
Title: |
The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney Disease
|
Acronym: |
|
Status: |
UNKNOWN
|
Study Results: |
NO
|
Results: |
|
Conditions: |
Kidney Failure, Chronic
|
Interventions: |
DRUG: Kremezin
|
Outcome Measures: |
Primary: Changes of FMD(Flow Mediated Dilatation), FMD (Flow Mediated Dilatation): percent change of FMD response to hyperemia and after sublingual nitroglycerin on brachial artery., 6 months | Secondary: Level of Indoxyl Sulfate, 3 months, 6 months
|
Sponsor/Collaborators: |
Sponsor: Ewha Womans University
|
Gender: |
ALL
|
Age: |
ADULT, OLDER_ADULT
|
Phases: |
PHASE4
|
Enrollment: |
30
|
Study Type: |
INTERVENTIONAL
|
Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
Start Date: |
2010-09
|
Completion Date: |
2011-12
|
Results First Posted: |
|
Last Update Posted: |
2010-07-07
|
Locations: |
Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of
|
URL: |
https://clinicaltrials.gov/show/NCT01157260
|